Panacea Life Sciences Holdings, Inc. Accounts Payable and Accrued Liabilities
Panacea Life Sciences Holdings, Inc. (PLSH) had Accounts Payable and Accrued Liabilities of $400.95 thousand as of 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Balance Sheet › Liabilities › Accounts Payable and Accrued Liabilities
us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent · last filed 2024-05-06
- 2024-03-31: Accounts Payable and Accrued Liabilities $400.95K.
- 2023-12-31: Accounts Payable and Accrued Liabilities $349.70K.
- 2023-09-30: Accounts Payable and Accrued Liabilities $361.71K.
- 2023-06-30: Accounts Payable and Accrued Liabilities $330.50K.
| Period end | Accounts Payable and Accrued Liabilities |
|---|---|
| 2024-03-31 | $400.95K 10-Q · filed 2024-05-06 |
| 2023-12-31 | $349.70K 10-Q · filed 2024-05-06 |
| 2023-09-30 | $361.71K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $330.50K 10-Q · filed 2023-08-15 |
| 2023-03-31 | $254.48K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $368.06K 10-Q · filed 2024-05-06 |
| 2021-12-31 | $24.59K 10-K · filed 2024-04-01 |
| 2021-09-30 | $20.07K 10-Q/A · filed 2021-12-20 |
| 2021-06-30 | $17.45K 10-Q/A · filed 2021-12-20 |
| 2020-12-31 | $121.30K 10-K · filed 2023-03-30 |
| 2019-12-31 | $254.79K 10-K · filed 2022-03-31 |